肾上腺意外瘤患者的临床评估与处理
恶性占5%–8%,高危因素包括年轻、肾上腺外恶性肿瘤史、大肿瘤伴不确定影像特征及双侧肿瘤。轻度自主皮质醇分泌可达30%–50%,与心血管疾病和代谢异常相关,所有患者需行地塞米松抑制试验。
要点
- 所有肾上腺意外瘤患者均需评估恶性可能和激素活性
- 恶性风险5%–8%,年轻、肾上腺外恶性肿瘤史、大肿瘤、双侧肿瘤风险更高
- 轻度自主皮质醇分泌可占30%–50%,需行地塞米松抑制试验筛查
核心结论
- 肾上腺意外瘤需同时评估恶性与激素活性以指导管理
- 轻度自主皮质醇分泌常见且与心血管及代谢异常相关
研究设计与样本
- 综述,总结肾上腺意外瘤诊断与评估的当前证据
- 聚焦最常见病因的管理
主要发现
- 恶性占5%–8%,年轻患者、有肾上腺外恶性肿瘤史、大肿瘤伴不确定影像特征及双侧肿瘤者风险更高
- 轻度自主皮质醇分泌可诊断于高达30%–50%的患者
- 自主皮质醇分泌与心血管疾病发病率增加和代谢异常相关
关键数值与推荐
- 所有肾上腺意外瘤患者均需行地塞米松抑制试验
临床怎么用
- 新发现肾上腺肿块时,应评估恶性可能和激素活性
- 管理需根据病因、合并症和患者偏好个体化
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adrenal tumors are commonly discovered incidentally on cross-sectional abdominal imaging performed for reasons other than adrenal mass. Incidence of adrenal tumors increased 10-fold in the past 2 decades, with most diagnosed in older adults. In any patient with a newly discovered adrenal mass, determining whether the adrenal mass is malignant and whether it is hormonally active is equally important to guide the best management. Malignancy is diagnosed in 5% to 8% of patients with adrenal tumors, with a higher risk in young patients, if history of extra-adrenal malignancy, in those with large adrenal tumors with indeterminate imaging characteristics, and in bilateral adrenal tumors. Although overt hormone excess is uncommon in adrenal incidentalomas, mild autonomous cortisol secretion can be diagnosed in up to 30% to 50% of patients. Because autonomous cortisol secretion is associated with increased cardiovascular morbidity and metabolic abnormalities, all patients with adrenal incidentalomas require work up with dexamethasone suppression test. Management of adrenal tumors varies based on etiology, associated comorbidities, and patient's preference. This article reviews the current evidence on the diagnosis and evaluation of patients with adrenal mass and focuses on management of the most common etiologies of adrenal incidentalomas.
引用
- Bancos I, Prete A. Approach to the Patient With Adrenal Incidentaloma. J Clin Endocrinol Metab. 2021. PMID: 34260734. doi:10.1210/clinem/dgab512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。